Treating mild hypothyroidism during pregnancy does not lead to improved cognitive functioning in children through five years of age, according to a recent study in the New England Journal of Medicine.
Browsing: Clinical Breakthroughs
Testosterone treatment in older men reduced anemia but did not improve cognitive function, and was associated with a significant increase in arterial plaque, according to Northwestern Medicine clinical trials.
A recent study assessed the barriers preventing individuals from participating in biobanking research projects, including concerns about informed consent and data sharing.
With evidence-based smartphone apps developed by our Center for Behavioral Intervention Technologies, mental healthcare is always within reach.
A Northwestern Medicine study has established a new safety index for a common group of chemotherapy drugs, by using a stem cell model to screen such therapies for cardiotoxicity.
A recent study, published in the New England Journal of Medicine, found a newer left ventricular assist device performed at least as well as existing devices on the market for patients with advanced heart failure.
A phase 1 clinical trial of venetoclax and rituximab combination therapy was shown to be an effective chemo-free treatment option for patients with difficult-to-treat chronic lymphocytic leukemia.
In recent Northwestern Medicine clinical trials, an experimental drug improved survival rates for patients with advanced midgut neuroendocrine tumors compared to a standard therapy.
An article published in JAMA recommends new updates to the red blood cell transfusion guidelines by the American Association of Blood Banks.
A novel national trial for people with no established alternative to treat their rare cancers is being co-led by Northwestern Medicine investigators, who helped conceive of and develop the project.